Genetic therapies for neurological disorders

Laura FitzPatrick*, Adrian Bird

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


In recent years, it has become increasingly apparent that many neurological disorders are underpinned by a genetic aetiology. This has resulted in considerable efforts to develop therapeutic strategies which can treat the disease-causing mutation, either by supplying a functional copy of the mutated gene or editing the genomic sequence. In this review, we will discuss the main genetic strategies which are currently being explored for the treatment of monogenic neurological disorders, as well as some of the challenges they face. In addition, we will address some of the ethical difficulties which may arise.

Original languageEnglish
Number of pages7
JournalHuman Genetics
Early online date22 Nov 2021
Publication statusE-pub ahead of print - 22 Nov 2021


Dive into the research topics of 'Genetic therapies for neurological disorders'. Together they form a unique fingerprint.

Cite this